Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Filters applied: . Clear all
Page 1
Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.
Massicano AVF, Lee S, Crenshaw BK, Aweda TA, El Sayed R, Super I, Bose R, Marquez-Nostra BV, Lapi SE. Massicano AVF, et al. Among authors: crenshaw bk. Cancer Biother Radiopharm. 2019 May;34(4):209-217. doi: 10.1089/cbr.2018.2654. Epub 2019 Jan 24. Cancer Biother Radiopharm. 2019. PMID: 30676778 Free PMC article.
89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma.
Benedetto R, Massicano AVF, Crenshaw BK, Oliveira R, Reis RM, Ara├║jo EB, Lapi SE. Benedetto R, et al. Among authors: crenshaw bk. Cancer Biother Radiopharm. 2019 Jun;34(5):288-296. doi: 10.1089/cbr.2018.2616. Epub 2019 Mar 13. Cancer Biother Radiopharm. 2019. PMID: 30865493 Free PMC article.
Feedback